A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment

Clinical trial NCT01836185 · COMPLETED

Trial details

NCT number: NCT01836185
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2013-04-01
Primary completion: 2013-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.